Skip to main content
Top
Published in: Calcified Tissue International 6/2011

01-06-2011 | Letter to the Editor

Circulating Fibroblast Growth Factor 23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation

Authors: James Mahon, Miriam Casey

Published in: Calcified Tissue International | Issue 6/2011

Login to get access

Excerpt

We read with interest in your November issue the article “Circulating Fibroblast Growth Factor 23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation” by Sridharan et al. While we welcome their input into elucidating the use of FGF-23 as a biomarker in osteoporosis treatment, we would like to address a few issues: the unusual baseline characteristics of the cohort studied and the small number of patients in the study. …
Literature
1.
go back to reference Delmas PD (1983) Effect of renal function on plasma levels of bone Gla-protein. Clin Endocrinol Metab 57(5):1028–1030CrossRef Delmas PD (1983) Effect of renal function on plasma levels of bone Gla-protein. Clin Endocrinol Metab 57(5):1028–1030CrossRef
Metadata
Title
Circulating Fibroblast Growth Factor 23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation
Authors
James Mahon
Miriam Casey
Publication date
01-06-2011
Publisher
Springer-Verlag
Published in
Calcified Tissue International / Issue 6/2011
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-011-9478-0

Other articles of this Issue 6/2011

Calcified Tissue International 6/2011 Go to the issue